BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37453366)

  • 1. Explainable artificial intelligence to predict and identify prostate cancer tissue by gene expression.
    Ramírez-Mena A; Andrés-León E; Alvarez-Cubero MJ; Anguita-Ruiz A; Martinez-Gonzalez LJ; Alcala-Fdez J
    Comput Methods Programs Biomed; 2023 Oct; 240():107719. PubMed ID: 37453366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an explainable artificial intelligence-based decision-supporting tool for prostate biopsy.
    Suh J; Yoo S; Park J; Cho SY; Cho MC; Son H; Jeong H
    BJU Int; 2020 Dec; 126(6):694-703. PubMed ID: 32455477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study.
    Zhang H; Ji J; Liu Z; Lu H; Qian C; Wei C; Chen S; Lu W; Wang C; Xu H; Xu Y; Chen X; He X; Wang Z; Zhao X; Cheng W; Chen X; Pang G; Yu G; Gu Y; Jiang K; Xu B; Chen J; Xu B; Wei X; Chen M; Chen R; Cheng J; Wang F
    BMC Med; 2023 Jul; 21(1):270. PubMed ID: 37488510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Risk Prediction and Online Calculation Based on Machine Learning Algorithm.
    Wang C; Chang QX; Wang XM; Wang KY; Wang H; Cui Z; Li CP
    Chin Med Sci J; 2022 Sep; 37(3):210-217. PubMed ID: 36321176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explainable artificial intelligence model for identifying COVID-19 gene biomarkers.
    Yagin FH; Cicek İB; Alkhateeb A; Yagin B; Colak C; Azzeh M; Akbulut S
    Comput Biol Med; 2023 Mar; 154():106619. PubMed ID: 36738712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.
    Eiro N; Medina A; Gonzalez LO; Fraile M; Palacios A; Escaf S; Fernández-Gómez JM; Vizoso FJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence in Magnetic Resonance Imaging-based Prostate Cancer Diagnosis: Where Do We Stand in 2021?
    Suarez-Ibarrola R; Sigle A; Eklund M; Eberli D; Miernik A; Benndorf M; Bamberg F; Gratzke C
    Eur Urol Focus; 2022 Mar; 8(2):409-417. PubMed ID: 33773964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI.
    Hamm CA; Baumgärtner GL; Biessmann F; Beetz NL; Hartenstein A; Savic LJ; Froböse K; Dräger F; Schallenberg S; Rudolph M; Baur ADJ; Hamm B; Haas M; Hofbauer S; Cash H; Penzkofer T
    Radiology; 2023 May; 307(4):e222276. PubMed ID: 37039688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
    Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
    Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Cardiovascular Disease Risk Factors in Adults with Explainable Artificial Intelligence.
    Kırboğa KK; Küçüksille EU
    Anatol J Cardiol; 2023 Nov; 27(11):657-663. PubMed ID: 37624075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation.
    Kan Y; Zhang Q; Hao J; Wang W; Zhuang J; Gao J; Huang H; Liang J; Marra G; Calleris G; Oderda M; Zhao X; Gontero P; Guo H
    Eur Radiol; 2020 Nov; 30(11):6274-6284. PubMed ID: 32524222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CVD22: Explainable artificial intelligence determination of the relationship of troponin to D-Dimer, mortality, and CK-MB in COVID-19 patients.
    Kırboğa KK; Küçüksille EU; Naldan ME; Işık M; Gülcü O; Aksakal E
    Comput Methods Programs Biomed; 2023 May; 233():107492. PubMed ID: 36965300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence for target prostate biopsy outcomes prediction the potential application of fuzzy logic.
    Checcucci E; Rosati S; De Cillis S; Vagni M; Giordano N; Piana A; Granato S; Amparore D; De Luca S; Fiori C; Balestra G; Porpiglia F
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):359-362. PubMed ID: 34480083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cell subtypes analyzed using artificial intelligence algorithm for predicting biochemical recurrence, immune escape potential, and immunotherapy response of prostate cancer.
    Xie X; Dou CX; Luo MR; Zhang K; Liu Y; Zhou JW; Huang ZP; Xue KY; Liang HY; Ouyang AR; Ma SX; Yang JK; Zhou QZ; Guo WB; Liu CD; Zhao SC; Chen MK
    Front Immunol; 2022; 13():946209. PubMed ID: 36569837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anemic condition in patients from clinical markers and explainable artificial intelligence.
    Darshan BSD; Sampathila N; Bairy MG; Belurkar S; Prabhu S; Chadaga K
    Technol Health Care; 2024 Feb; ():. PubMed ID: 38339945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing artificial intelligence for prostate cancer management.
    Zhu L; Pan J; Mou W; Deng L; Zhu Y; Wang Y; Pareek G; Hyams E; Carneiro BA; Hadfield MJ; El-Deiry WS; Yang T; Tan T; Tong T; Ta N; Zhu Y; Gao Y; Lai Y; Cheng L; Chen R; Xue W
    Cell Rep Med; 2024 Apr; 5(4):101506. PubMed ID: 38593808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random forest-based modelling to detect biomarkers for prostate cancer progression.
    Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
    Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An active learning based classification strategy for the minority class problem: application to histopathology annotation.
    Doyle S; Monaco J; Feldman M; Tomaszewski J; Madabhushi A
    BMC Bioinformatics; 2011 Oct; 12():424. PubMed ID: 22034914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches.
    Alarcón-Zendejas AP; Scavuzzo A; Jiménez-Ríos MA; Álvarez-Gómez RM; Montiel-Manríquez R; Castro-Hernández C; Jiménez-Dávila MA; Pérez-Montiel D; González-Barrios R; Jiménez-Trejo F; Arriaga-Canon C; Herrera LA
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):431-443. PubMed ID: 35422101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.